<DOC>
	<DOCNO>NCT01609907</DOCNO>
	<brief_summary>The objective study compare pharmacokinetics single oral administration rosuvastatin valsartan separately versus coadministration rosuvastatin valsartan healthy male volunteer .</brief_summary>
	<brief_title>Pharmacokinetic Drug Interaction Between Rosuvastatin Valsartan</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Healthy male volunteer age 20 year 50 year Have body mass index ( BMI ) 19kg/m2 27kg/m2 inclusive Eligible subject acceptable medical history , physical examination laboratory test , ECG screen period Able follow instruction participate whole procedure trial Have sign write informed consent voluntary , prior procedure , use form approve local Institutional Review Board detail explanation drug Anticipate adult female sexual partner , possibility pregnant breastfeed take step prevent conception study Have history cardiovascular disorder ( congestive heart failure , complication coronary artery stenosis stroke etc . ) , respiratory disorder , renal disorder ( severe renal failure etc . ) , liver disorder ( moderate severe liver failure etc . ) endocrine system disorder ( diabetic , impair glucose tolerance etc . ) , digestive system disorder , central nervous system disorder , mental illness malignant tumor Have history gastrointestinal disease ( Crohn 's disease , ulcer etc . ) , gastrointestinal surgery ( simple appendectomy herniotomy exclude ) affect absorption drug Have suffer clinically significant disease within 30 day prior first administration Have know hypersensitivity history clinically significant hypersensitivity drug include class drug rosuvastatin valsartan , drug ( aspirin , antibiotic etc . ) Have genetic myopathy , family history myopathy , history myopathy drug Have systolic blood pressure high 150mmHg low 90mmHg , diastolic blood pressure high 100mmHg low 60mmHg , pulse rate 100times/min less 40times/min Have history drug abuse show positive drug abuse drug screen test Participated clinical trial within 90 day prior first administration Have use herbal medicine , prescription drug , generic medicine within 30 day , 14 day 7 day prior first administration , respectively ( provide , however , condition judge eligible investigator , subject participate trial ) Donated whole blood blood component within 60 day 30 day prior first administration , respectively , receive transfusion within 30 day prior first administration Excessive alcohol drinker ( &gt; 140g/week ; 1 glass 12° wine ( 125mL ) = 12.0g , 1 glass 4° beer ( 250mL ) = 8g , 0.5 bottle soju ( 180mL ) = 28.8g ) Heavy smoker ( &gt; 20 cigarettes/day ) Excessive caffeine drinker ( &gt; 4 cups/day ) Shown positive serum test ( HBsAg , HCV Ab , HIV Ab test ) Subject judge ineligible principal investigator subinvestigator accord various reason include abnormal value clinical laboratory test Continuous increase liver enzyme level ( AST , ALT ) unknown cause active liver disorder patient liver enzyme level increase 3 time normal upper limit Severe renal disorder patient ( creatinine clearance ( Cr ) &lt; 10mL/min calculated Modification Diet Renal Disease method )</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Drug interaction</keyword>
	<keyword>YH14700</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>Valsartan</keyword>
	<keyword>Yuhan</keyword>
</DOC>